Active Ingredient(s):Telavancin FDA Approved: * September 11, 2009 Pharm Company: *THERAVANCE INC Category:Antibiotics
Telavancin (trade name Vibativ) is a bactericidal lipoglycopeptide for use in MRSA or other Gram-positive infections. Telavancin is a semi-synthetic derivative of vancomycin.
The FDA approved the drug in September 2009 for complicated skin and skin structure infections (cSSSI), and in June 2013 for hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus.
* May have multiple approval dates, manufacturers, or labelers.
Vibativ 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution